GIBTULIO 25 – Empagliflozin 25mg Tablets

GIBTULIO 25 Tablets contain Empagliflozin 25 mg, an oral antidiabetic medication belonging to the SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor class. It is indicated for the management of Type 2 Diabetes Mellitus in adults to improve glycemic control when used alongside a healthy diet and regular exercise. Empagliflozin lowers blood sugar by preventing glucose reabsorption in the kidneys, allowing excess glucose to be eliminated through urine.

In addition to helping manage Type 2 diabetes, Empagliflozin 25 mg is approved in many regions to reduce the risk of cardiovascular death in adults with Type 2 diabetes and established cardiovascular disease. It may also be prescribed for eligible patients with heart failure or chronic kidney disease according to local prescribing guidelines. GIBTULIO 25 Tablets should be used under the supervision of a qualified healthcare professional, with regular monitoring of blood glucose levels, kidney function, and overall health.

Manufactured in WHO-GMP compliant facilities under strict quality standards, GIBTULIO 25 Tablets are supplied by trusted pharmaceutical exporters from India to importers, wholesalers, distributors, pharmacies, hospitals, and healthcare institutions worldwide. We provide export-grade packaging, complete regulatory documentation, competitive wholesale pricing, and reliable international shipping.